GHRS
NASDAQ · Pharmaceuticals
Gh Research Plc
$30.27
-0.37 (-1.21%)
Open$30.95
Previous Close$30.64
Day High$31.44
Day Low$29.45
52W High$31.00
52W Low$11.32
Volume—
Avg Volume304.1K
Market Cap2.08B
P/E Ratio—
EPS$-0.91
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+59.3% upside
Current
$30.27
$30.27
Target
$48.23
$48.23
$34.28
$48.23 avg
$66.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 289.57M | 263.52M | 305.92M |
| Net Income | 46.13M | 45.80M | 47.46M |
| Profit Margin | 15.9% | 17.4% | 15.5% |
| EBITDA | 85.32M | 72.54M | 88.44M |
| Free Cash Flow | 28.26M | 23.23M | 28.03M |
| Rev Growth | +11.0% | +19.2% | +2.7% |
| Debt/Equity | 0.68 | 0.55 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |